health
Ministry of Health's Decision to Ban Clinical Trials at SBPB "Kovin"
Patient safety has been severely compromised, clinical study data from the "Kovin" Special Psychiatric Hospital (SBPB) is unusable, and sponsors cannot expect to achieve their so-called endpoints in the study – efficacy and safety, according to, among other things, the Ministry of Health's decision of March 5, 2026, which permanently bans a total of eight clinical trials at that health institution, marking the epilogue of a major recent scandal in domestic healthcare.
TL;DR
- Ministry of Health permanently banned eight clinical trials at "Kovin" Special Psychiatric Hospital.
- Patient safety was severely compromised, and clinical study data is unusable.
- Vulnerable patients with dementia and Alzheimer's were involved in irregular trial processes.
- Issues included non-compliance with inclusion criteria, irregular informed consent, unreported adverse events, prohibited medication, and data inconsistencies.
- A medical technician who reported the issues was fired and has initiated legal proceedings.
- The hospital management initially denied the allegations but was contradicted by the Ministry's decision.